ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 361,000
-15,500 (-4.12%)
At close: Feb 6, 2026
ALTEOGEN Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 202,182 | 102,855 | 96,523 | 28,806 | 38,746 | 42,426 |
Other Revenue | - | - | - | -0 | - | - |
| 202,182 | 102,855 | 96,523 | 28,806 | 38,746 | 42,426 | |
Revenue Growth (YoY) | 171.84% | 6.56% | 235.08% | -25.65% | -8.67% | 45.15% |
Cost of Revenue | 45,927 | 38,813 | 65,382 | 24,352 | 33,045 | 23,748 |
Gross Profit | 156,255 | 64,041 | 31,141 | 4,454 | 5,701 | 18,678 |
Selling, General & Admin | 15,405 | 12,748 | 14,466 | 14,232 | 12,714 | 10,537 |
Research & Development | 28,440 | 24,550 | 25,306 | 18,660 | 7,480 | 7,691 |
Amortization of Goodwill & Intangibles | 841.67 | 191.45 | 164.25 | 117.16 | 95.06 | 69.28 |
Other Operating Expenses | 570.63 | 511.85 | 337.76 | 319.91 | 221.69 | 141.66 |
Operating Expenses | 45,963 | 38,637 | 40,878 | 33,828 | 20,893 | 18,736 |
Operating Income | 110,292 | 25,404 | -9,737 | -29,374 | -15,192 | -58.17 |
Interest Expense | -7,798 | -674.94 | -670.88 | -425.48 | -604.66 | -796.78 |
Interest & Investment Income | 11,267 | 7,819 | 5,298 | 3,869 | 2,066 | 901.41 |
Currency Exchange Gain (Loss) | 629.13 | 7,055 | 230.33 | 1,691 | 2,971 | -2,395 |
Other Non Operating Income (Expenses) | 7,481 | -3,156 | 1,196 | 3,026 | -11,700 | -15,295 |
EBT Excluding Unusual Items | 121,852 | 36,447 | -3,683 | -21,213 | -22,460 | -17,643 |
Gain (Loss) on Sale of Investments | -47.39 | 24.59 | 31.23 | 11,360 | 13,310 | - |
Gain (Loss) on Sale of Assets | -10.51 | - | 109.96 | 127.41 | -18.48 | -80.78 |
Asset Writedown | -2.12 | -14.97 | -22.17 | -527.51 | -1,525 | -9.5 |
Other Unusual Items | - | 155.01 | - | 282.58 | - | 41.91 |
Pretax Income | 121,792 | 36,612 | -3,564 | -9,970 | -10,694 | -17,692 |
Income Tax Expense | -1,369 | -24,078 | 17.83 | 108.05 | 893.17 | 583.06 |
Earnings From Continuing Operations | 123,161 | 60,690 | -3,582 | -10,078 | -11,588 | -18,275 |
Minority Interest in Earnings | 2,767 | 1,562 | 210.44 | 1,932 | 5,313 | 2,453 |
Net Income | 125,928 | 62,252 | -3,372 | -8,146 | -6,275 | -15,822 |
Net Income to Common | 125,926 | 62,252 | -3,372 | -8,146 | -6,275 | -15,822 |
Shares Outstanding (Basic) | 53 | 53 | 52 | 51 | 51 | 50 |
Shares Outstanding (Diluted) | 53 | 53 | 52 | 51 | 51 | 50 |
Shares Change (YoY) | 1.33% | 2.82% | 0.74% | 1.32% | 0.54% | 4.47% |
EPS (Basic) | 2360.58 | 1172.04 | -65.27 | -158.85 | -123.98 | -314.29 |
EPS (Diluted) | 2262.96 | 1163.00 | -65.27 | -159.00 | -124.00 | -314.29 |
Free Cash Flow | 72,979 | 50,326 | -8,985 | -24,298 | -23,046 | -3,609 |
Free Cash Flow Per Share | 1364.88 | 947.50 | -173.92 | -473.81 | -455.33 | -71.70 |
Gross Margin | 77.28% | 62.26% | 32.26% | 15.46% | 14.71% | 44.03% |
Operating Margin | 54.55% | 24.70% | -10.09% | -101.97% | -39.21% | -0.14% |
Profit Margin | 62.28% | 60.52% | -3.49% | -28.28% | -16.20% | -37.29% |
Free Cash Flow Margin | 36.10% | 48.93% | -9.31% | -84.35% | -59.48% | -8.51% |
EBITDA | 113,771 | 28,254 | -6,403 | -26,719 | -13,041 | 1,811 |
EBITDA Margin | 56.27% | 27.47% | -6.63% | -92.75% | -33.66% | 4.27% |
D&A For EBITDA | 3,479 | 2,850 | 3,334 | 2,654 | 2,151 | 1,869 |
EBIT | 110,292 | 25,404 | -9,737 | -29,374 | -15,192 | -58.17 |
EBIT Margin | 54.55% | 24.70% | -10.09% | -101.97% | -39.21% | -0.14% |
Advertising Expenses | - | 218.22 | 21.68 | 4.51 | 16.78 | 17.74 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.